April 9, 2021 Comments Off on New patent expiration for Novartis drug UTIBRON Posted in: Uncategorized
Annual Drug Patent Expirations for UTIBRON Utibron is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are eighteen patents protecting…
The post New patent expiration for Novartis drug UTIBRON appeared fi…
April 9, 2021 Comments Off on New patent expiration for Novartis drug SEEBRI Posted in: Uncategorized
Annual Drug Patent Expirations for SEEBRI Seebri is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are twelve patents protecting…
The post New patent expiration for Novartis drug SEEBRI appeared first o…
